Lozano F, Simarro M, Calvo J, Vilà J M, Padilla O, Bowen M A, Campbell K S
Servei d'Immunologia, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Villarroel, Barcelona, Spain.
Crit Rev Immunol. 2000;20(4):347-58.
The CD5 lymphocyte surface glycoprotein is a coreceptor involved in the modulation of antigen-specific receptor-mediated activation and differentiation signals. Although first considered a costimulatory molecule in mature peripheral T cells, recent studies of CD5-/- mice have opened the possibility that CD5 may also mediate inhibitory signals that attenuate TCR/CD3- and BCR-mediated triggering in thymocytes and a subgroup of B cells (B-1a cells), respectively. The ultimate molecular basis for these differential modulatory properties of CD5, depending on the context of lymphocyte subset and differentiation stage, are presently unknown and are an issue of current intensive investigation. Here, we review recent reports, both contradictory and complementary, focused on CD5-mediated molecular intracellular signaling events that could provide the basis for its immunomodulatory properties.
CD5淋巴细胞表面糖蛋白是一种共受体,参与调节抗原特异性受体介导的激活和分化信号。尽管最初被认为是成熟外周T细胞中的共刺激分子,但最近对CD5基因敲除小鼠的研究表明,CD5也可能介导抑制性信号,分别减弱胸腺细胞和B细胞亚群(B-1a细胞)中TCR/CD3和BCR介导的触发。目前尚不清楚CD5这些依赖于淋巴细胞亚群和分化阶段的不同调节特性的最终分子基础,这是当前深入研究的一个问题。在这里,我们综述了最近的一些报告,这些报告既有矛盾的也有互补的,重点关注CD5介导的分子细胞内信号事件,这些事件可能为其免疫调节特性提供基础。